Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 3520581, 16 pages
https://doi.org/10.1155/2017/3520581
Review Article

Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis

1Center of Laboratory Medicine, General Hospital of Ningxia Medical University, Yinchuan 750004, China
2Institute of Human Stem Cell Research, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China

Correspondence should be addressed to Xiaoming Liu

Received 28 December 2016; Revised 29 March 2017; Accepted 12 April 2017; Published 15 May 2017

Academic Editor: Teresa Zelante

Copyright © 2017 Juan Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Pauwels, A. S. Buist, P. M. Calverley, C. R. Jenkins, S. S. Hurd, and GOLD Scientific Committee, “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 5, pp. 1256–1276, 2001. View at Publisher · View at Google Scholar
  2. J. C. Hogg and W. Timens, “The pathology of chronic obstructive pulmonary disease,” Annual Review of Pathology, vol. 4, pp. 435–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Reuter, H. Beckert, and C. Taube, “Take the Wnt out of the inflammatory sails: modulatory effects of Wnt in airway diseases,” Laboratory Investigation, vol. 96, no. 2, pp. 177–185, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Nusse, “Cell signalling: disarming Wnt,” Nature, vol. 519, no. 7542, pp. 163–164, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. E. E. Morrisey, “Wnt signaling and pulmonary fibrosis,” The American Journal of Pathology, vol. 162, no. 5, pp. 1393–1397, 2003. View at Publisher · View at Google Scholar
  6. J. E. Pongracz and R. A. Stockley, “Wnt signalling in lung development and diseases,” Respiratory Research, vol. 7, no. 1, p. 15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Ota, H. A. Baarsma, D. E. Wagner, A. Hilgendorff, and M. Königshoff, “Linking bronchopulmonary dysplasia to adult chronic lung diseases: role of WNT signaling,” Molecular and Cellular Pediatrics, vol. 3, no. 1, p. 34, 2016. View at Publisher · View at Google Scholar
  8. T. N. Perkins, M. A. Dentener, F. R. Stassen et al., “Alteration of canonical and non-canonical WNT-signaling by crystalline silica in human lung epithelial cells,” Toxicology and Applied Pharmacology, vol. 301, pp. 61–70, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Rydell-Tormanen, X. H. Zhou, O. Hallgren et al., “Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased beta-catenin inhibition and increased Wnt5a/b interaction,” Physiological Reports, vol. 4, no. 5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Chilosi, V. Poletti, A. Zamo et al., “Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis,” The American Journal of Pathology, vol. 162, no. 5, pp. 1495–1502, 2003. View at Publisher · View at Google Scholar
  11. M. Konigshoff, N. Balsara, E. M. Pfaff et al., “Functional Wnt signaling is increased in idiopathic pulmonary fibrosis,” PloS One, vol. 3, no. 5, article e2142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Chilosi, V. Poletti, and A. Rossi, “The pathogenesis of COPD and IPF: distinct horns of the same devil?” Respiratory Research, vol. 13, no. 1, p. 3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Foronjy, K. Imai, T. Shiomi et al., “The divergent roles of secreted frizzled related protein-1 (SFRP1) in lung morphogenesis and emphysema,” The American Journal of Pathology, vol. 177, no. 2, pp. 598–607, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Kneidinger, A. O. Yildirim, J. Callegari et al., “Activation of the WNT/beta-catenin pathway attenuates experimental emphysema,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 6, pp. 723–733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Komiya and R. Habas, “Wnt signal transduction pathways,” Organogenesis, vol. 4, no. 2, pp. 68–75, 2008. View at Google Scholar
  16. A. Tury, K. Tolentino, and Y. Zou, “Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis,” Developmental Neurobiology, vol. 74, no. 8, pp. 839–850, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Tamai, M. Semenov, Y. Kato et al., “LDL-receptor-related proteins in Wnt signal transduction,” Nature, vol. 407, no. 6803, pp. 530–535, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Wehrli, S. T. Dougan, K. Caldwell et al., “Arrow encodes an LDL-receptor-related protein essential for wingless signalling,” Nature, vol. 407, no. 6803, pp. 527–530, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. R. T. Moon, B. Bowerman, M. Boutros, and N. Perrimon, “The promise and perils of Wnt signaling through beta-catenin,” Science, vol. 296, no. 5573, pp. 1644–1646, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Niehrs, “The complex world of WNT receptor signalling,” Nature Reviews. Molecular Cell Biology, vol. 13, no. 12, pp. 767–779, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Gomez-Orte, B. Saenz-Narciso, S. Moreno, and J. Cabello, “Multiple functions of the noncanonical Wnt pathway,” Trends in Genetics, vol. 29, no. 9, pp. 545–553, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. T. Veeman, J. D. Axelrod, and R. T. Moon, “A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling,” Developmental Cell, vol. 5, no. 3, pp. 367–377, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Kikuchi, H. Yamamoto, A. Sato, and S. Matsumoto, “New insights into the mechanism of Wnt signaling pathway activation,” International Review of Cell and Molecular Biology, vol. 291, pp. 21–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Malinauskas and E. Y. Jones, “Extracellular modulators of Wnt signalling,” Current Opinion in Structural Biology, vol. 29, pp. 77–84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Niehrs, “Function and biological roles of the Dickkopf family of Wnt modulators,” Oncogene, vol. 25, no. 57, pp. 7469–7481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Mao and C. Niehrs, “Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling,” Gene, vol. 302, no. 1-2, pp. 179–183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Liang, H. He, R. Lv et al., “Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma,” Tumour Biology, vol. 36, no. 2, pp. 1245–1250, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Ma and M. O. Hottiger, “Crosstalk between Wnt/beta-catenin and NF-kappaB signaling pathway during inflammation,” Frontiers in Immunology, vol. 7, p. 378, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Villasenor, E. Madrid-Paulino, R. Maldonado-Bravo, A. Urbán-Aragón, L. Pérez-Martínez, and G. Pedraza-Alva, “Activation of the Wnt pathway by mycobacterium tuberculosis: a Wnt-Wnt situation,” Frontiers in Immunology, vol. 8, p. 50, 2017. View at Publisher · View at Google Scholar
  30. O. Silva-Garcia, J. J. Valdez-Alarcon, and V. M. Baizabal-Aguirre, “The Wnt/beta-catenin signaling pathway controls the inflammatory response in infections caused by pathogenic bacteria,” Mediators of Inflammation, vol. 2014, Article ID 310183, p. 7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Li, J. Shi, J. Yang et al., “A Wnt/beta-catenin negative feedback loop represses TLR-triggered inflammatory responses in alveolar epithelial cells,” Molecular Immunology, vol. 59, no. 2, pp. 128–135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Boucherat, M. C. Morissette, S. Provencher, S. Bonnet, and F. Maltais, “Bridging lung development with chronic obstructive pulmonary disease. Relevance of developmental pathways in chronic obstructive pulmonary disease pathogenesis,” American Journal of Respiratory and Critical Care Medicine, vol. 193, no. 4, pp. 362–375, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. A. H. Gifford, M. Matsuoka, L. Y. Ghoda, R. J. Homer, and R. I. Enelow, “Chronic inflammation and lung fibrosis: pleotropic syndromes but limited distinct phenotypes,” Mucosal Immunology, vol. 5, no. 5, pp. 480–484, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Selman, A. Pardo, L. Barrera et al., “Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 2, pp. 188–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Iwata, I. Yoshino, S. Yoshida et al., “A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan oncology group 6711 L (PEOPLE study),” Respiratory Research, vol. 17, no. 1, p. 90, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. T. E. King Jr., W. Z. Bradford, S. Castro-Bernardini et al., “A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis,” The New England Journal of Medicine, vol. 370, no. 22, pp. 2083–2092, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Azuma, Y. Taguchi, T. Ogura et al., “Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment,” Respiratory Research, vol. 12, no. 1, p. 143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. S. D. Nathan, C. Albera, W. Z. Bradford et al., “Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis,” The Lancet Respiratory Medicine, vol. 5, no. 1, pp. 33–41, 2017. View at Publisher · View at Google Scholar
  39. W. A. Wuyts, M. Kolb, S. Stowasser, W. Stansen, J. T. Huggins, and G. Raghu, “First data on efficacy and safety of Nintedanib in patients with idiopathic pulmonary fibrosis and forced vital capacity of </=50% of predicted value,” Lung, vol. 194, no. 5, pp. 739–743, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. R. M. Strieter, “Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel,” Chest, vol. 128, Supplement 1, no. 5, pp. 526S–532S, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. B. B. Moore, W. E. Lawson, T. D. Oury, T. H. Sisson, K. Raghavendran, and C. M. Hogaboam, “Animal models of fibrotic lung disease,” American Journal of Respiratory Cell and Molecular Biology, vol. 49, no. 2, pp. 167–179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Li, J. He, J. Wei, W. C. Cho, and X. Liu, “Diversity of epithelial stem cell types in adult lung,” Stem Cells International, vol. 2015, Article ID 728307, p. 11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Milara, T. Peiro, A. Serrano, and J. Cortijo, “Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke,” Thorax, vol. 68, no. 5, pp. 410–420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Konigshoff and O. Eickelberg, “WNT signaling in lung disease: a failure or a regeneration signal?” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 1, pp. 21–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Wang, J. Ahmed, G. Wang et al., “Down-regulation of the canonical Wnt beta-catenin pathway in the airway epithelium of healthy smokers and smokers with COPD,” PloS One, vol. 6, no. 4, article e14793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. H. A. Baarsma, W. Skronska-Wasek, K. Mutze et al., “Noncanonical WNT-5A signaling impairs endogenous lung repair in COPD,” The Journal of Experimental Medicine, vol. 214, no. 1, pp. 143–163, 2017. View at Publisher · View at Google Scholar
  47. H. A. Baarsma, A. I. Spanjer, G. Haitsma et al., “Activation of WNT/beta-catenin signaling in pulmonary fibroblasts by TGF-beta(1) is increased in chronic obstructive pulmonary disease,” PloS One, vol. 6, no. 9, article e25450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Konigshoff, M. Kramer, N. Balsara et al., “WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis,” The Journal of Clinical Investigation, vol. 119, no. 4, pp. 772–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Zou, S. Liu, J. Hu et al., “Nicotine reduces the levels of surfactant proteins A and D via Wnt/beta-catenin and PKC signaling in human airway epithelial cells,” Respiratory Physiology & Neurobiology, vol. 221, pp. 1–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. I. H. Heijink, H. G. de Bruin, R. Dennebos et al., “Cigarette smoke-induced epithelial expression of WNT-5B: implications for COPD,” The European Respiratory Journal, vol. 48, no. 2, pp. 504–515, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. F. E. Uhl, S. Vierkotten, D. E. Wagner et al., “Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures,” The European Respiratory Journal, vol. 46, no. 4, pp. 1150–1166, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. W. Zou, Y. Zou, Z. Zhao, B. Li, and P. Ran, “Nicotine-induced epithelial-mesenchymal transition via Wnt/beta-catenin signaling in human airway epithelial cells,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 304, no. 4, pp. L199–L209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. E. M. van Dijk, M. H. Menzen, A. I. Spanjer, L. D. Middag, C. A. Brandsma, and R. Gosens, “Noncanonical WNT-5B signaling induces inflammatory responses in human lung fibroblasts,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 310, no. 11, pp. L1166–L1176, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Guo, T. Wang, Y. Wu et al., “WNT/beta-catenin signaling regulates cigarette smoke-induced airway inflammation via the PPARdelta/p38 pathway,” Laboratory Investigation, vol. 96, no. 2, pp. 218–229, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. I. H. Heijink, H. G. de Bruin, M. van den Berge et al., “Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstructive pulmonary disease,” Thorax, vol. 68, no. 8, pp. 709–716, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Skronska-Wasek, K. Mutze, H. A. Baarsma et al., “Reduced frizzled receptor 4 expression prevents WNT/beta-catenin-driven alveolar lung repair in COPD,” American Journal of Respiratory and Critical Care Medicine, 2017, [Epub ahead of print]. View at Publisher · View at Google Scholar
  57. H. A. Baarsma, W. Skronska-Wasek, K. Mutze et al., “Correction: noncanonical WNT-5A signaling impairs endogenous lung repair in COPD,” The Journal of Experimental Medicine, vol. 214, no. 2, p. 565, 2017. View at Publisher · View at Google Scholar
  58. A. I. Spanjer, H. A. Baarsma, L. M. Oostenbrink et al., “TGF-beta-induced profibrotic signaling is regulated in part by the WNT receptor frizzled-8,” The FASEB Journal, vol. 30, no. 5, pp. 1823–1835, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Wang, J. Dai, Z. Sun et al., “Targeted inhibition of disheveled PDZ domain via NSC668036 depresses fibrotic process,” Experimental Cell Research, vol. 331, no. 1, pp. 115–122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. E. M. Pfaff, S. Becker, A. Gunther, and M. Königshoff, “Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis,” The European Respiratory Journal, vol. 37, no. 1, pp. 79–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. T. H. Kim, S. H. Kim, J. Y. Seo et al., “Blockade of the Wnt/beta-catenin pathway attenuates bleomycin-induced pulmonary fibrosis,” The Tohoku Journal of Experimental Medicine, vol. 223, no. 1, pp. 45–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Meuten, A. Hickey, K. Franklin et al., “WNT7B in fibroblastic foci of idiopathic pulmonary fibrosis,” Respiratory Research, vol. 13, no. 1, p. 62, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Oda, K. Yatera, H. Izumi et al., “Profibrotic role of WNT10A via TGF-beta signaling in idiopathic pulmonary fibrosis,” Respiratory Research, vol. 17, no. 1, p. 39, 2016. View at Publisher · View at Google Scholar
  64. D. R. Newman, W. S. Sills, K. Hanrahan et al., “Expression of WNT5A in idiopathic pulmonary fibrosis and its control by TGF-beta and WNT7B in human lung fibroblasts,” The Journal of Histochemistry and Cytochemistry, vol. 64, no. 2, pp. 99–111, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. W. R. Henderson Jr., E. Y. Chi, X. Ye et al., “Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 32, pp. 14309–14314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. A. P. Lam, J. D. Herazo-Maya, J. A. Sennello et al., “Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 2, pp. 185–195, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. V. Aumiller, N. Balsara, J. Wilhelm, A. Günther, and M. Königshoff, “WNT/beta-catenin signaling induces IL-1beta expression by alveolar epithelial cells in pulmonary fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 49, no. 1, pp. 96–104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Xu, W. H. Cui, W. C. Zhou et al., “Activation of Wnt/beta-catenin signalling is required for TGF-beta/Smad2/3 signalling during myofibroblast proliferation,” Journal of Cellular and Molecular Medicine, 2017, [Epub ahead of print]. View at Publisher · View at Google Scholar
  69. Y. Xu, T. Mizuno, A. Sridharan et al., “Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis,” JCI Insight, vol. 1, no. 20, article e90558, 2016. View at Publisher · View at Google Scholar
  70. S. Xiong, X. Pan, L. Xu et al., “Regulatory T cells promote beta-catenin-mediated epithelium-to-mesenchyme transition during radiation-induced pulmonary fibrosis,” International Journal of Radiation Oncology, Biology, Physics, vol. 93, no. 2, pp. 425–435, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. X. Chen, C. Shi, X. Meng et al., “Inhibition of Wnt/beta-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-beta1 and FGF-2,” Experimental and Molecular Pathology, vol. 101, no. 1, pp. 22–30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. E. De Langhe, C. Aznar-Lopez, V. De Vooght, J. A. Vanoirbeek, F. P. Luyten, and R. J. Lories, “Secreted frizzled related proteins inhibit fibrosis in vitro but appear redundant in vivo,” Fibrogenesis & Tissue Repair, vol. 7, no. 1, p. 14, 2014. View at Publisher · View at Google Scholar
  73. Z. Wang, J. N. Zhang, X. F. Hu et al., “Effects of pentoxifylline on Wnt/beta-catenin signaling in mice chronically exposed to cigarette smoke,” Chinese Medical Journal, vol. 123, no. 19, pp. 2688–2694, 2010. View at Google Scholar
  74. Z. Sun, C. Wang, C. Shi et al., “Activated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosis,” International Journal of Molecular Medicine, vol. 33, no. 5, pp. 1097–1109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Andersson-Sjoland, J. C. Karlsson, and K. Rydell-Tormanen, “ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling,” Laboratory Investigation, vol. 96, no. 2, pp. 206–217, 2016. View at Publisher · View at Google Scholar · View at Scopus
  76. J. A. Sennello, A. V. Misharin, A. S. Flozak et al., “Lrp5/beta-catenin signaling controls lung macrophage differentiation and inhibits resolution of fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 56, no. 2, pp. 191–201, 2017. View at Publisher · View at Google Scholar
  77. Y. Wang, J. Liu, J. Chen, T. Feng, and Q. Guo, “MiR-29 mediates TGFbeta 1-induced extracellular matrix synthesis through activation of Wnt/beta -catenin pathway in human pulmonary fibroblasts,” Technology and Health Care, vol. 23, Supplement 1, pp. S119–S125, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Tamimi, D. Serdarevic, and N. A. Hanania, “The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications,” Respiratory Medicine, vol. 106, no. 3, pp. 319–328, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. H. A. Baarsma, M. H. Menzen, A. J. Halayko, H. Meurs, H. A. Kerstjens, and R. Gosens, “Beta-catenin signaling is required for TGF-beta1-induced extracellular matrix production by airway smooth muscle cells,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 301, no. 6, pp. L956–L965, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Vukmirovic, J. D. Herazo-Maya, J. Blackmon et al., “Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with idiopathic pulmonary fibrosis,” BMC Pulmonary Medicine, vol. 17, no. 1, p. 15, 2017. View at Publisher · View at Google Scholar
  81. M. Chilosi, C. Doglioni, B. Murer, and V. Poletti, “Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis,” Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, vol. 27, no. 1, pp. 7–18, 2010. View at Google Scholar
  82. L. J. Vuga, A. Ben-Yehudah, E. Kovkarova-Naumovski et al., “WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 5, pp. 583–589, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. J. L. van der Velden, A. S. Guala, S. E. Leggett, J. Sluimer, E. C. Badura, and Y. M. Janssen-Heininger, “Induction of a mesenchymal expression program in lung epithelial cells by wingless protein (Wnt)/beta-catenin requires the presence of c-Jun N-terminal kinase-1 (JNK1),” American Journal of Respiratory Cell and Molecular Biology, vol. 47, no. 3, pp. 306–314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. K. D. Salazar, S. M. Lankford, and A. R. Brody, “Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 297, no. 5, pp. L1002–L1011, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Zanforlin, C. Sorino, and G. F. Sferrazza Papa, “Towards a multi-dimensional approach to COPD,” Minerva Medica, vol. 107, Supplement 1, no. 3, pp. 1–6, 2016. View at Google Scholar
  86. C. Garvey, “Recent updates in chronic obstructive pulmonary disease,” Postgraduate Medicine, vol. 128, no. 2, pp. 231–238, 2016. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Hattab, S. Alhassan, M. Balaan, M. Lega, and A. C. Singh, “Chronic obstructive pulmonary disease,” Critical Care Nursing Quarterly, vol. 39, no. 2, pp. 124–130, 2016. View at Publisher · View at Google Scholar · View at Scopus
  88. Z. Ge, B. Li, X. Zhou, Y. Yang, and J. Zhang, “Basic fibroblast growth factor activates beta-catenin/RhoA signaling in pulmonary fibroblasts with chronic obstructive pulmonary disease in rats,” Molecular and Cellular Biochemistry, vol. 423, no. 1-2, pp. 165–174, 2016. View at Publisher · View at Google Scholar · View at Scopus
  89. K. Kumawat, M. H. Menzen, I. S. Bos et al., “Noncanonical WNT-5A signaling regulates TGF-beta-induced extracellular matrix production by airway smooth muscle cells,” The FASEB Journal, vol. 27, no. 4, pp. 1631–1643, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. C. Li, S. Bellusci, Z. Borok, and P. Minoo, “Non-canonical WNT signalling in the lung,” Journal of Biochemistry, vol. 158, no. 5, pp. 355–365, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Rangarajan, M. L. Locy, T. R. Luckhardt, and V. J. Thannickal, “Targeted therapy for idiopathic pulmonary fibrosis: where to now?” Drugs, vol. 76, no. 3, pp. 291–300, 2016. View at Publisher · View at Google Scholar · View at Scopus
  92. C. S. King and S. D. Nathan, “Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities,” The Lancet Respiratory Medicine, vol. 5, no. 1, pp. 72–84, 2017. View at Publisher · View at Google Scholar
  93. Z. Yan, Z. Kui, and Z. Ping, “Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis,” Autoimmunity Reviews, vol. 13, no. 10, pp. 1020–1025, 2014. View at Publisher · View at Google Scholar · View at Scopus
  94. Q. Sun, S. Guo, C. C. Wang et al., “Cross-talk between TGF-beta/Smad pathway and Wnt/beta-catenin pathway in pathological scar formation,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 6, pp. 7631–7639, 2015. View at Google Scholar
  95. N. A. Hasaneen, J. Cao, A. Pulkoski-Gross, S. Zucker, and H. D. Foda, “Extracellular matrix metalloproteinase inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts,” Respiratory Research, vol. 17, no. 1, p. 17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Kumawat, M. H. Menzen, R. M. Slegtenhorst, A. J. Halayko, M. Schmidt, and R. Gosens, “TGF-beta-activated kinase 1 (TAK1) signaling regulates TGF-beta-induced WNT-5A expression in airway smooth muscle cells via Sp1 and beta-catenin,” PloS One, vol. 9, no. 4, article e94801, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Kumawat and R. Gosens, “WNT-5A: signaling and functions in health and disease,” Cellular and Molecular Life Sciences, vol. 73, no. 3, pp. 567–587, 2016. View at Publisher · View at Google Scholar · View at Scopus
  98. B. Zhou, Y. Liu, M. Kahn et al., “Interactions between beta-catenin and transforming growth factor-beta signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP),” The Journal of Biological Chemistry, vol. 287, no. 10, pp. 7026–7038, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. L. Chen, T. Wang, X. Wang et al., “Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats,” Respiratory Research, vol. 10, no. 1, p. 55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. C. Wang, H. Zhu, Z. Sun et al., “Inhibition of Wnt/beta-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury,” American Journal of Physiology. Cell Physiology, vol. 307, no. 3, pp. C234–C244, 2014. View at Publisher · View at Google Scholar · View at Scopus
  101. M. V. Karamouzis, P. A. Konstantinopoulos, and A. G. Papavassiliou, “Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis,” Cell Research, vol. 17, no. 4, pp. 324–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. X. Wang, W. Dai, Y. Wang, Q. Gu, D. Yang, and M. Zhang, “Blocking the Wnt/beta-catenin pathway by lentivirus-mediated short hairpin RNA targeting beta-catenin Gene suppresses silica-induced lung fibrosis in mice,” International Journal of Environmental Research and Public Health, vol. 12, no. 9, pp. 10739–10754, 2015. View at Publisher · View at Google Scholar · View at Scopus
  103. J. L. Riffell, C. J. Lord, and A. Ashworth, “Tankyrase-targeted therapeutics: expanding opportunities in the PARP family,” Nature Reviews. Drug Discovery, vol. 11, no. 12, pp. 923–936, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Klee, M. Lehmann, D. E. Wagner, H. A. Baarsma, and M. Königshoff, “WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts,” Scientific Reports, vol. 6, p. 20547, 2016. View at Publisher · View at Google Scholar · View at Scopus
  105. A. P. Binks, M. Beyer, R. Miller, and R. J. LeClair, “Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function,” Physiological Reports, vol. 5, no. 5, article e13115, 2017. View at Publisher · View at Google Scholar